萊迪思半導體 LSCC 深 滬
等待開盤 10-01 09:30:00 美东时间
73.32
+1.650
+2.30%
華盛通- 最 高73.49
- 今 開72.23
- 成交量 188.44万股
- 最 低 71.65
- 昨 收 71.67
- 總市值 100.45亿
- 52周最高 76.615
- 市盈率 靜 165.88
- 換手率 1.38%
- 52周最低 34.685
- 委 比 86.08%
- 總股本 1.37亿
- 歷史最高 98.30
- 量 比 1.13
- 振 幅 2.57%
- 歷史最低 3.165
- 每 手 1
- 風險率 10.35%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Keybanc Maintains Overweight on Lattice Semiconductor, Raises Price Target to $85
Keybanc analyst John Vinh maintains Lattice Semiconductor (NASDAQ:LSCC) with a Overweight and raises the price target from $70 to $85.
09-30 22:48
A Look Into Lattice Semiconductor Inc's Price Over Earnings
In the current session, the stock is trading at $72.00, after a 0.91% increase. Over the past month, Lattice Semiconductor Inc. (NASDAQ: LSCC) stock increased by 6.49%, and in the past year, by 38.54%.
09-30 01:04
杭州拱墅两企入选省级工业互联网平台 赋能产业数字化转型
浙江省经信厅最新公布的第六批省级工业互联网平台名单中，拱墅区杭州禾迈电力电子与杭州罗莱迪思科技两家企业成功入选。此次入选的禾迈智联工业互联网平台和罗莱迪思城市智...
09-25 09:33
Competitor Analysis: Evaluating NVIDIA And Competitors In Semiconductors & Semiconductor Equipment Industry
In the ever-changing and fiercely competitive business landscape, conducting th...
09-24 23:00
Lattice Semiconductor (LSCC) Receives a Hold from CFRA
In a report released today, Angelo Zino from CFRA maintained a Hold rating on L...
09-24 04:05
美股大行评级 | 潜在涨幅1650.0%！Ascendiant Capital维持GRI Bio"买入"评级，目标价上调至35美元
今日重点评级关注：Ascendiant Capital：维持GRI Bio"买入"评级，目标价从34美元升至35美元；Ascendiant Capital：维持Atossa Therapeutics"买入"评级，目标价从7.5美元升至7.75美元
09-23 09:52
Needham Maintains Buy on Lattice Semiconductor, Raises Price Target to $80
Needham analyst N. Quinn Bolton maintains Lattice Semiconductor (NASDAQ:LSCC) with a Buy and raises the price target from $70 to $80.
09-22 17:22
Insights Into NVIDIA's Performance Versus Peers In Semiconductors & Semiconductor Equipment Sector
In the fast-paced and cutthroat world of business, conducting thorough company ...
09-12 23:00
美股大行评级 | 潜在涨幅208.48%！HC Wainwright & Co.上调Microbot Medical目标价至12美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Microbot Medical"买入"评级，目标价从9美元升至12美元；Maxim Group：维持Neuphoria Therapeutics"买入"评级，目标价从18美元升至35美元
09-12 12:53
Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-11 20:08
